Tranquil Clinical and Research Consulting Services
Welcome,         Profile    Billing    Logout  
 0 Trials 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Bauer, Andrew
ReTRIACt, NCT05579327 / 2022-001478-78: Withdrawal of Tiratricol Treatment in Males with Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)

Recruiting
3
16
Europe, US
Tiratricol, Placebo
Rare Thyroid Therapeutics International AB, Premier Research Group plc, Egetis Therapeutics
Monocarboxylate Transporter 8 Deficiency, Allan-Herndon-Dudley Syndrome
04/25
06/25
NCT02396459 / 2019-003370-35: Triac Trial II in MCT8 Deficiency Patients

Active, not recruiting
2
22
Europe, US, RoW
Triac, Tiratricol, Teatrois
Rare Thyroid Therapeutics International AB, Erasmus Medical Center
Allan-Herndon-Dudley Syndrome
05/24
06/26
NCT05911399: Expanded Access Program for Tiratricol in Patients with Monocarboxylate Transporter 8 Deficiency

Available
N/A
US
Tiratricol
Rare Thyroid Therapeutics International AB, AnovoRx, Egetis Therapeutics
Monocarboxylate Transporter 8 Deficiency, Allan-Herndon-Dudley Syndrome
 
 
MIRROR, NCT04494295: The Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation

Recruiting
N/A
500
US
Aurora Surgiscope System
Integra LifeSciences Corporation, Icahn School of Medicine at Mount Sinai, Oculus Imaging LLC
Supratentorial Hemorrhage
10/28
10/29
STAR, NCT04994756: Stroke Thrombectomy and Aneurysm Registry

Recruiting
N/A
40000
Europe, Canada, Japan, US, RoW
Stroke/Thrombectomy/Aneurysm-specific surgical procedures
Medical University of South Carolina
Stroke, Thromboses, Intracranial, Aneurysm, Brain
01/55
01/55
Babu, Annette
ReTRIACt, NCT05579327 / 2022-001478-78: Withdrawal of Tiratricol Treatment in Males with Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)

Recruiting
3
16
Europe, US
Tiratricol, Placebo
Rare Thyroid Therapeutics International AB, Premier Research Group plc, Egetis Therapeutics
Monocarboxylate Transporter 8 Deficiency, Allan-Herndon-Dudley Syndrome
04/25
06/25
HOPE-3, NCT05126758: A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy

Recruiting
3
102
US
CAP-1002, Cardiosphere-Derived Cells (CDCs), Placebo
Capricor Inc.
Muscular Dystrophies, Muscular Dystrophy, Duchenne, Muscular Disorders, Atrophic, Muscular Diseases, Neuromuscular Diseases, Genetic Diseases, X-Linked, Genetic Diseases, Inborn, Nervous System Diseases
12/24
12/26
SYNAPSE-SMA, NCT05794139 / 2022-002301-24: Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy

Recruiting
2
54
Europe, Canada, US
NMD670, Placebo
NMD Pharma A/S, NMD Pharma A/S
Spinal Muscular Atrophy
07/25
07/25
EXPLORE44, NCT05670730: Study of AOC 1044 in Healthy Adult Volunteers and Participants with Duchenne Muscular Dystrophy (DMD) Mutations Amenable to Exon 44 Skipping

Active, not recruiting
1/2
64
US
AOC 1044, Placebo, Saline
Avidity Biosciences, Inc.
Duchenne Muscular Dystrophy, Exon 44
01/25
01/25
CDLink, NCT04972604: CureDuchenne Link®: A Resource for Research

Recruiting
N/A
5000
US
CureDuchenne
Duchenne Muscular Dystrophy, Becker Muscular Dystrophy
07/31
07/31

Download Options